Open access
Oct 2026
Molecular mechanisms underlying the effectiveness of triiodothyroacetic acid (Triac) in patients with resistance to thyroid hormone β (RTHβ): a multicentre, international, retrospective cohort study
It is documented that Triac lowers elevated FT4 concentrations in patients with RTHβ effectively and suggested that Triac can act via different modes of action, with activation of the wild-type receptor being a relevant mechanism.
Wen-Jun Liao, F. Marelli, C. Moran et al.
· EBioMedicine · 0 citations